KMT2A
About
Location: 11q23.3
Mappings
Biomarkers
KMT2A is involved in the following curated biomarkers.
| Name | Biomarker type | Propositions | Statements |
|---|---|---|---|
| t(KMT2A;v) | Rearrangement | 4 | 4 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | t(KMT2A;v) | Acute Lymphoid Leukemia | Revumenib | |
| Sensitivity (+) | t(KMT2A;v) | Acute Myeloid Leukemia | Revumenib | |
| Sensitivity (+) | t(KMT2A;v) | Burkitt Lymphoma | Revumenib | |
| Sensitivity (+) | t(KMT2A;v) | Acute Leukemias of Ambiguous Lineage | Revumenib |